Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2020 Earnings Conference Call February 25, 2021 9:00 AM ET
Company Participants
Kristen Sheppard - VP, IR
John Butler - CEO, President & Director
David Spellman - SVP, CFO & Treasurer
Conference Call Participants
Christopher Raymond - Piper Sandler & Co.
Difei Yang - Mizuho Securities
Antonio Arce - H.C. Wainwright & Co.
David Lebowitz - Morgan Stanley
Eric Joseph - JPMorgan Chase & Co.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to Akebia Therapeutics Fourth Quarter 2020 Financial Results Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Kristen Sheppard, Senior Vice President of Investor Relations. Thank you. Please go ahead.
Kristen Sheppard
Thank you, and welcome to Akebia's Fourth Quarter and Fiscal Year 2020 Financial Results and Business Update Conference Call. Please note that the press release detailing our results for the fourth quarter and fiscal year 2020 was issued earlier this morning and is available on our Investor Relations website. For your convenience, a replay of today's call will also be available on our website shortly after we conclude today's event. Joining me for today's event is John Butler, our Chief Executive Officer; and David Spellman, our Chief Financial Officer.
Before we begin, I'd like to remind everyone that this call includes forward-looking statements. Each forward-looking statement contained in this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information regarding these factors is described in the forward-looking statements section of the press release we issued earlier today, as well as in the risk factors in management's discussion and analysis sections of our most recent quarterly and annual reports filed with the
- Read more current AKBA analysis and news
- View all earnings call transcripts